Illumina Dumps On Roche Reality

I had a posting on 20 December 02012 titled: "Illumina Spikes On Roche Speculation". Yesterday, on 7 January 02012, Illumina (ILMN) lost almost 8% of its market value because Roche said they are not interested in acquiring Illumina.

On non-Roche related news, yesterday Illumina issues a press release announcing they had acquired "Verinata Health, Inc., a leading provider of non-invasive tests for the early identification of fetal chromosomal abnormalities, for consideration of $350 million plus up to $100 million in milestone payments through 2015."

ILMN closed yesterday (02013.01.07) at $50.90. 52-week range: $28.72 - $57.00.